Outcomes of bictegravir/emtricitabine/tenofovir alafenamide versus efavirenz-based regimens in central China: a real-world assessment

• Yongquan Peng,
• Xujian Cao,
• Yating Wang,
• Weiwei Yu,
• Ziwei Zeng,
• Min Wang,
• Yanjie Yin

Affiliations

Yongquan Peng

1 Graduate Collaborative Training Base of the First Hospital of Changsha, University of South China, Hengyang, Hunan 421001, China

Xujian Cao

1 Graduate Collaborative Training Base of the First Hospital of Changsha, University of South China, Hengyang, Hunan 421001, China

Yating Wang

1 Graduate Collaborative Training Base of the First Hospital of Changsha, University of South China, Hengyang, Hunan 421001, China

Weiwei Yu

2 Institute of HIV/AIDS, First Hospital of Changsha, Changsha, Hunan 410000, China.

Ziwei Zeng

2 Institute of HIV/AIDS, First Hospital of Changsha, Changsha, Hunan 410000, China.

Min Wang

2 Institute of HIV/AIDS, First Hospital of Changsha, Changsha, Hunan 410000, China.

Yanjie Yin